This Mother's Day, Bitvae is proud to stand with families and communities worldwide to promote oral health and wellness
NEW YORK, May 9, 2023 (Newswire.com)
-
With Mother's Day just around the corner, Bitvae is excited to offer its customers a fantastic opportunity to celebrate this special day with amazing discounts on its revolutionary oral care products.
Oral health is essential for overall well-being, and with Bitvae's commitment to making oral care easy and enjoyable, there's no better time to show your appreciation for the mom in your life with the gift of a healthy and beautiful smile.
From May 8 to May 14, customers can avail of special discounts on Bitvae's top-quality oral care products, including the following:
Bitvae's oral care products are the perfect gift for any mom. Whether they're busy and on-the-go or looking for a luxurious self-care ritual, Bitvae has got it covered. Bitvae's D2 Electric Toothbrush and S2 Smart Electric Toothbrush, both ADA-approved, are the perfect addition to any busy mom's oral care routine. With their stylish design and superior cleaning power, these toothbrushes are trusted by thousands of satisfied customers.
For moms who want to take their oral care routine to the next level, Bitvae's C2 Portable Water Flosser is a powerful flosser that removes up to 99.9% of food debris and dental plaque, ensuring a thorough clean that brushing alone cannot provide. With its compact design, the C2 is perfect for busy moms on-the-go who want to maintain healthy teeth and gums wherever they are.
"Bitvae is proud to celebrate Mother's Day by offering these fantastic discounts on our high-quality oral care products. We want to empower moms to take control of their family's oral health with confidence and make oral care a daily routine that is simple, enjoyable, and effective for everyone," said Hugh Zou, founder, and CEO of Bitvae.
Give the gift of a healthy and beautiful smile this Mother's Day with Bitvae's affordable and high-quality oral care products. Visit Bitvae's Amazon Storefront to take advantage if these deals.
About Bitvae Established in Texas, Bitvae is committed to making oral care easy and enjoyable. Bitvae infuses the latest technologies into thoughtful products that fit into their customers' lifestyles and are perfect for use at home and on the go.
For more information, check out Bitvae's storefront on Amazon or website and stay up to date with the brand on Instagram, TikTok and Facebook (@bitvae.official).
Amplify Her Voice with a.i. solutions Join a.i. solutions on May 25, 2023, from 5-8 pm for this exclusive event to support extraordinary women. Get your free ticket here: https:\/\/www.eventbrite.com\/e\/amplify-her-voice-a-fireside-chat-tickets-595979439547?aff=escb&utm-source=cp&utm-term=l
LANHAM, Md., May 9, 2023 (Newswire.com)
-
The women of a.i. solutions®, a leading space mission engineering services provider and space software applications developer, will be hosting their second annual Fireside Chat — Amplify Her Voice on May 25 from 5-8 p.m. This event will be held in person, and live-streamed, from the company headquarters in Lanham, Maryland.
The women of the executive leadership team have curated a distinguished guest panel of five powerhouse women from across the industry who will share their stories, reflect upon the value of embracing young women, and discuss their commitment to moving the needle by increasing the number of women engineers. This event will bring together more than 100 women in STEM industries, the Department of Defense, and academia with the goal of amplifying the voices of women while reminding them that "I shine, when she shines."
"a.i. solutions is committed to supporting our collaborative culture with programs that promote diversity, equity, inclusion, and accessibility," said Marisa Acheé, a.i. solutions' Vice President of Business Development. "I am privileged to be a leader at a company that recognizes the importance of women in executive roles and the value of diversity in supporting our customers' missions."
Visit a.i. solutions and the Amplify Her Voice webpage to view full event details, including the guest panelist lineup, and to register for this must-attend free event. The program is open to the public. Tickets are going fast, register today.
About a.i. solutions
Founded in 1996, a.i. solutions provides an engaged workforce that delivers innovative products and services enabling access to space and to ensure national security. a.i. solutions' services and products span space mission engineering, missile defense systems assurance, launch vehicle services, cyber and information assurance, and the FreeFlyer astrodynamics software. For additional information, please visit ai-solutions.com and @ai_sol on Twitter.
Contact Information:
Doug Stewart
Vice President of Strategic Marketing, Appleton [email protected]
407-246-0092 ext. 1
GRAND RAPIDS, Mich., May 9, 2023 (Newswire.com)
-
SpendMend, a leading provider of cost-cycle management solutions for the healthcare industry, announced today that Derick Elliott has joined the company as Chief Commercial Officer. In this role, Derick will oversee the company's sales and marketing efforts while leveraging his experience in healthcare, building platform solutions, and running sales organizations to package, scale, and deliver SpendMend's complete cost-cycle solution.
Derick is a medical technology commercial leader with a track record of building high-performing teams that deliver market-leading results for companies featuring large and diverse solution portfolios. He has previously served in transformational leadership roles for Stryker Corporation and Cardinal Health, including business strategy, M&A integration, and commercialization. He is recognized as a change agent who accelerates growth and helps healthcare entities improve clinical, operational, and financial outcomes.
"I am excited to join SpendMend at such a critical time for the healthcare industry," said Derick. "I am passionate about leveraging technology and data to drive innovation and deliver patient-centric solutions. I am thrilled to join a team that is dedicated to improving financial performance for clients while maintaining an unwavering focus on patient care."
Dan Geelhoed, CEO of SpendMend, added, "We are thrilled to have Derick join our team. He brings a wealth of experience and expertise in healthcare and will be instrumental in driving innovation at SpendMend. We are committed to helping healthcare organizations tackle the challenge of dark data in their supply chain and Derick's experience will be invaluable in that effort."
Steve Rogers, Managing Director at Morgan Stanley Capital Partners, added, "Derick has a demonstrated track record of success in the healthcare industry, and we are excited to see how he will seek to leverage his experience to drive growth and innovation at SpendMend. We are confident that Derick's leadership and strategic vision will help to propel SpendMend to even greater heights."
About SpendMend
SpendMend is the leading provider of tech-enabled, cost-saving solutions in the healthcare industry. By combining data, proprietary technology, and analytics with healthcare expertise, SpendMend partners with healthcare networks to illuminate dark data and expose hidden costs in meaningful ways. The company's mission is to help its clients improve patient care through innovative cost-saving solutions.
Contact Information:
Kylee Savage
Marketing Manager [email protected]
616-257-8331
First product to the market from the 'ProLon EveryDay' product line is the L-Spread, rich in Longevity Nuts sourced from Italy's Longevity Area and formulated based on the Longevity Diet by Dr. Valter Longo.
LOS ANGELES, May 9, 2023 (Newswire.com)
-
L-Nutra Inc., the world's leading nutrition technology company pioneering the discovery and commercialization of novel nutrition products that impact both the body's metabolism and cellular rejuvenation, announces today the launch of a new pipeline of nutrition called 'ProLon EveryDay'.
ProLon EveryDay is the result of 30 years of research to identify foods and ingredients from around the globe that taste great; can be consumed every day; are consistently associated with improved health, disease reduction and longevity extension; contain no toxins; and have minimal impact on the environment and carbon emission. The ProLon Everyday ingredients and foods are based on pre-clinical, clinical and epidemiological studies as well as on studies of the diets of populations with record longevity.
The first product to market under this new line of Nutrition is the L-Spread which contains 74% almonds, a major Longevity Nut that is consistently correlated with healthy human longevity. Scientific studies show that daily consumption of almonds may lower risk of mortality, notably from cardiovascular diseases and cancer. The L-Spread is based on a precision nutrition formulation developed by Dr. Valter Longo, head of the Longevity Institute at University of Southern California and selected TIME Magazine's top 50 most influential people in Health. The Longevity nutrition formulation aims at controlling factors associated with biological aging such as insulin and IGF. The L-Spread contains plant-based proteins, healthy fats and low sugar. It is Gluten-Free, Soy-Free, Vegan, and Non-GMO.
"We searched around the world for great tasting almonds produced in an area with record longevity and decided to source from the Longevity Area of South Italy known for its thriving centenarians", said Dr. Joseph Antoun, M.D., Ph.D., CEO, and Chairman of L-Nutra Inc.
"The L-Spread is based on a Nutrition For Longevity Formulation that Dr. Valter Longo researched for 30 years at USC's Longevity Lab and published in the Longevity Diet book and a Cell 2022 article," said Dr. Will Hsu, M.D., Chief Medical Officer at L-Nutra Inc.
L-Nutra is leading the discovery, design, and commercialization of novel nutrition products and programs with the mission of adding more life to human life. Current commercial products focus on wellness and healthy aging, including ProLon® 5 Day Fasting Mimicking Nutrition the first and only clinically tested, five-day fasting nutrition program designed to allow your body to enter a fasting state while still consuming nutrient-dense foods. L-Nutra also created the 1-day fasting nutrition kit ProLon Reset™, ProLon Intermittent Fasting Bar®, the first nutrition bar specifically designed and clinically tested to support intermittent fasting and ProLon Fasting Shake, the first drink tested to keep the body in fasting mode. Nutrition for Longevity® is L-Nutra's science-backed, chef-curated meal program, featuring farm-to-table meals formulated to address the nutritional deficiencies in today's commercially grown produce. For more info, visit https://l-nutra.com/.
Q & B Foods, Inc., a leading producer of high-quality mayonnaise, is excited to announce the launch of its newest product, KEWPIE Vegan Mayo Dressing and Spread in a 64-oz size.
LOS ANGELES, May 9, 2023 (Newswire.com)
-
Q & B Foods, Inc., a leading producer of high-quality mayonnaise, is excited to announce the launch of its newest product, KEWPIE Vegan Mayo Dressing and Spread in a 64-oz size. This innovative mayonnaise alternative is made with all plant-based ingredients and is specifically designed to cater to vegan, vegetarian, Kosher, and Gluten-Free diets. KEWPIE Vegan Mayo Dressing and Spread is certified by The Plant Based Foods Association, which ensures that it contains no animal-derived ingredients.
KEWPIE Vegan Mayo Dressing and Spread sets itself apart from competitors by offering a rich, creamy flavor and silky smooth texture that closely resembles traditional mayonnaise. Unlike other vegan mayonnaise options on the market, KEWPIE's version delivers an exceptional taste that is perfect for adding depth and flavor to a wide range of dishes, from salads and sandwiches to dips and dressings.
With an ambient shelf life of nine months, KEWPIE Vegan Mayo Dressing and Spread is an ideal option for both home use and foodservice businesses. The brand's commitment to producing high-quality, great-tasting mayonnaise alternatives has resulted in a product that is versatile and easy to incorporate into various dishes without sacrificing flavor.
"Q&B is proud to introduce our Vegan Mayo Dressing and Spread, which represents our commitment to providing delicious and plant-based alternatives for consumers with diverse dietary needs," said Jerry Shepherd, President of Q & B Foods, Inc., Kewpie Group Member. "We believe that this new product, certified by The Plant Based Foods Association, will not only meet but exceed the expectations of our customers, and we look forward to sharing it with the world."
KEWPIE Vegan Mayo Dressing and Spread is now available for purchase online and on Amazon. For more information about the product, search "kewpie vegan mayo dressing" on Amazon or visit https://www.kewpieshop.com.
About Kewpie Kewpie has been a trusted name in mayonnaise production for nearly a century. Their expertise and commitment to quality ensure that customers receive only the finest ingredients in every product. Kewpie continues to innovate and expand its product offerings to cater to diverse dietary needs while maintaining the delicious taste and high-quality standards for which they are known.
Contact Information:
Q & B Foods Inc. [email protected]
(626) 334-8090 x217
Yang Yang, PhD, of Purdue University is the recipient of a major 5-year grant for Personalized Treatment Development in SCN2A-Related Disorders
EAST LONGMEADOW, Mass., May 9, 2023 (Newswire.com)
-
The FamilieSCN2A Foundation, a nonprofit organization dedicated to improving the lives of individuals with SCN2A-related disorders (SRDs), has awarded a first-stage $2.5 million dollar research grant to a Purdue University researcher.
Yang Yang, associate professor of Medicinal Chemistry and Molecular Pharmacology in Purdue's College of Pharmacy received the grant to support the development of personalized treatments for this group of disorders after peer-review by scientific experts in the field.
Funding is committed over the next 5 years by a restricted, single-family donation through the FamilieSCN2A Foundation's Hodgkin-Huxley (HH) Research Grant. The grant was named to honor Nobel Prize winners Dr. Alan Hodgkin and Dr. Andrew Huxley for their innovative discovery of action potentials in neurons.
SRDs are a group of rare genetic conditions caused by mutations in the SCN2A gene, which encodes an ion channel that is essential for the function of brain cells. These disorders can cause a wide range of neurological symptoms including difficult-to-control seizures, profound autism, developmental delays, movement disorders, and intellectual disabilities.
The five-year grant will support Yang's research aimed at developing personalized treatments for a splice-site SCN2A variant through n=1 drug development. The goal of n=1 projects is to create treatments tailored to the unique genetic and clinical profiles of individual patients, with the hope of improving outcomes and quality of life for all those affected by these disorders.
"We are incredibly grateful to the family who helped make this grant possible," said Leah Myers, founder of the FamilieSCN2A Foundation. "Through their generosity and commitment to research, this grant will help to accelerate the development of personalized treatments for SRDs, a critical need for families affected by these devastating conditions."
Shawn Egan, Chief Scientific Officer for the FamilieSCN2A Foundation agreed.
"We expect this project to take a large leap forward into the understanding and treatment of SRDs with splice site mutations, which is an area that has been understudied to date," he said.
The FamilieSCN2A Foundation and its scientific advisors reviewed the project proposal prior to awarding the grant and will manage the project to ensure that it meets the highest scientific standards while advancing the foundation's mission.
Yang said he is honored to have received the award and looks forward to the research advances it will enable.
"I am extremely honored and privileged to receive this grant from the FamilieSCN2A Foundation to embark on this uncharted journey to fight SRD together with the families," he said. "This grant is built on discoveries that were funded by prior FamilieSCN2A Awards and National Institutes of Health (NIH) research grants, which laid a solid foundation for us to take the next giant leap to tackle SRDs.
"With this award, we are excited to build new disease models and work on developing personalized treatments for SRDs, including cutting-edge pharmacological and genetic interventions. We greatly appreciate the trust from the donor family with this substantial award to initiate this high-risk/high-reward research to advance transformative n=1 therapeutic discovery and investigate innovative approaches to drug development for many. I believe this award will help us move closer to a future where individuals with SRDs can receive treatments tailored to their specific needs."
"The award will contribute to the Purdue College of Pharmacy's robust pursuit of impactful discoveries that improve lives," said Eric Barker, Jeannie and Jim Chaney Dean of Pharmacy.
"The Purdue College of Pharmacy is grateful to the FamilieSCN2A Foundation for supporting Dr. Yang's impactful research," he said. "We know that in situations like this, the passion for discovery is fueled by deeply personal motivations for the families involved. We are committed to advancing basic and translational research that helps move discoveries from the laboratory to directly improving patients' lives through new therapeutic interventions."
According to Yang, most rare diseases are genetic disorders and do not have a cure; however, recent progress in precision medicine and gene therapy are offering hope for treating these types of disorders.
The Hodgkin Huxley Award will advance precision and personalized medicine to treat these disorders and improve quality of life for the people affected by them. It will also greatly contribute to ongoing translational research within the Purdue College of Pharmacy's Department of Medicinal Chemistry and Molecular Pharmacology, and the growing drug discovery pipeline at Purdue University, according to Department Head Zhong-Yin Zhang, who also directs Purdue's Institute for Drug Discovery.
"Dr. Yang's research has tremendous potential to improve the lives of countless people through personalized therapies," he said. "We are extremely grateful to the donor family and to the FamilieSCN2A Foundation for their generosity in advancing this incredibly important research."
Yang specializes in neurological diseases, including autism, epilepsy, pain, and dementia; pharmacogenomics; and gene therapy. "He is a leading investigator for the Purdue Institute for Integrative Neuroscience (PIIN)," said Chris Rochet, Professor of Medicinal Chemistry and Molecular Pharmacology and the John and Donna Krenicki Director of PIIN.
PIIN is committed to unraveling mysteries of the healthy brain and advancing treatment of central nervous system disorders.
"Since arriving at Purdue in 2017, Dr. Yang has made important contributions to the field of neuroscience by discovering changes in neuron firing that account for altered brain function in individuals with epilepsy or autism spectrum disorder," Rochet said. "We thank the FamilieSCN2A Foundation for their generous investment in Dr. Yang's research program, and offer our full support to help maximize the long-term impact of this groundbreaking study."
The FamilieSCN2A Foundation is committed to accelerating research, building community, and advocating to improve the lives of those affected by SCN2A-related disorders around the world.
For more information about the FamilieSCN2A Foundation and its mission, or to donate to this cause visit www.scn2a.org.
Glorium Technologies, a prominent healthcare software development company, highlights the potential solution to the problem of the global shortage of 18 million healthcare workers in 2030 by enhancing telehealth coverage worldwide.
PRINCETON, N.J., May 9, 2023 (Newswire.com)
-
According to the World Health Organization (WHO) and the World Bank, there could be a shortage of 18 million health workers by 2030, with developing countries in South Asia and Sub-Saharan Africa expected to be hit the hardest. This factor, coupled with global youth unemployment and limited job prospects, especially in the healthcare industry, presents a challenging situation for access to healthcare worldwide.
Telehealth as an innovative way of connecting patients with physicians could be the answer to ensuring everyone has access to quality healthcare, according to Glorium Technologies experts.
With the COVID-19 outbreak leading to increased demand for remote care, telehealth has grown significantly. However, there is still room for expansion. The market was valued at $83.5 billion in 2022 and is projected to reach $455.26 billion by 2030, with a compound annual growth rate (CAGR) of 24.0% from 2023 to 2030. And here is one of the main reasons why—the Internet and smartphone penetration help to address the gaps in the delivery and availability of telehealth services.
But to make telemedicine accessible for people across the globe, telemedicine coverage should be balanced due to gaping differences in infrastructure and capabilities between countries. Some of them have already established robust networks of remote services for their citizens, and others still need access assistance.
A quick glance at facts and figures shows that in 2022, North America dominated the industry, accounting for 47.1% of the total revenue, mainly due to high healthcare IT expenditure and higher penetration of internet and smartphone users. The Asia Pacific region is projected to witness the fastest growth rate during the forecast period due to the rising geriatric population, combined with advancements in digital health and research initiatives undertaken by key players. Regarding the problems with very low incomes and limited opportunities for employment and education in areas like Africa and South America, patients can receive remote care abroad using telehealth solutions and address health issues in this way.
"Considering the projected shortage of medical professionals, now is an opportune moment to invest in infrastructure and telehealth software development," says Andrei Kasyanau, CEO and Co-Founder of Glorium Technologies. "In cases where patients cannot receive an accurate diagnosis due to a scarcity of physicians, they can send their test results to medical experts in other regions, who can provide the necessary diagnosis and treatment plans."
In addition to enhancing access to care, telehealth can automate and digitize administrative tasks, freeing up medical professionals' time and enabling them to dedicate more attention to their patients. The technology can also help medical professionals develop networking and exchange valuable information, creating group chats and video rooms for communication and information exchange.
About the company
Glorium Technologies is a top-shelf bespoke software developmentcompany that has delivered 100+ products to its clients. The headquarters is located in the US. Since its establishment in 2010, the Company has been helping startups grow by offering top-notch technology designs. Its centers have mastered Business Intelligence, AR/VR, Blockchain, Machine Learning, Big Data, Artificial Intelligence, and many other top tech trends.
Glorium Technologies' achievements are recognized by the international IT community and awarded by the Inc. 5000, Clutch, GoodFirms, AppFutura, Wadline, etc.
Contact Information:
Maksym Arslanov
Content and Communications Specialist [email protected]
Headquartered in Wadsworth, Ohio, for over 85 years, Foundation Wellness is a house of wellness brands including PowerStep, Foot Petals, FLAT SOCKS and Doctor Hoy's.
WADSWORTH, Ohio, May 9, 2023 (Newswire.com)
-
Foundation Wellness, the leading U.S. manufacturer of insoles and orthotics, has announced its acquisition of CURREX, a leading brand of insoles designed for athletes and active individuals. CURREX is the #1 brand in retail running stores across the U.S. and Germany. With the acquisition of CURREX, Foundation Wellness expands its product offerings and strengthens its position as a top provider of wellness solutions for individuals looking to live active and pain-free lives.
"We're thrilled to welcome CURREX and its leading brand of performance insoles to the Foundation Wellness family. CURREX has an impressive following of consumers who rely on their technically advanced insoles, and we believe that they are very complementary with our PowerStep #1 Podiatrist recommended insole line. With our shared passion for delivering exceptional products that improve the lives of consumers, we're confident that together, we'll continue to grow the CURREX brand in the U.S. and around the world," said Sean Williams, CEO of Foundation Wellness.
"Foundation Wellness is the perfect partner for CURREX, as they share our commitment to innovation, performance and customer satisfaction. We are confident that CURREX will continue to thrive with this partnership and are proud to have built the brand to where it is today," said Bjorn Gustafsson, CEO of CURREX.
About Foundation Wellness: Foundation Wellness, based in Wadsworth, Ohio for nearly 90 years, offers wellness solutions and houses popular brands including PowerStep, Foot Petals, FLAT SOCKS, and Doctor Hoy's. PowerStep is the top orthotic insole recommended by Podiatrists, delivering proven pain relief and prevention. The company sells branded products to sports and specialty retailers, direct to consumers, and private label products to leading OEMs and distributors in foot care, orthopedic soft goods, safety, and military markets. For more information, visit https://www.foundationwellness.com.
About CURREX: CURREX distributes high-performance insoles for athletes and active individuals, using innovative technology to tailor insoles to the user's specific needs. Founded in Hamburg, Germany in 2000, their products are trusted by professional athletes and coaches worldwide to improve performance, reduce injury risk, and enhance foot comfort. Visit their website at https://currex.us/ for more information.
Contact Information:
Kayla Boyet
Vice President of Branded Marketing, Foundation Wellness [email protected]
Revolutionary UGC Shortcut Program Empowers Aspiring Content Creators to Turn Passions Into Profitable Careers
Kate Rebel: The Inspiring Force Behind Rebel Socials' UGC Shortcut Kate Rebel, founder of Rebel Socials, demonstrates the use of a popular beauty product in her well-lit creative space, showcasing her expertise in crafting engaging and effective User-Generated Content
PHILADELPHIA, May 9, 2023 (Newswire.com)
-
Rebel Socials, founded by Kate Rebel, is excited to announce the launch of their groundbreaking program, UGC Shortcut. This innovative program is designed to provide aspiring content creators with the tools, insights, and mentorship needed to turn their passion into a rewarding career. The UGC Shortcut program aims to transform lives by helping creators achieve financial freedom and success in the rapidly evolving digital world.
Kate Rebel, a stay-at-home mom turned successful lifestyle, health and wellness content creator based in Philadelphia, PA, discovered her true potential after realizing the opportunities available in the rapidly growing User Generated Content (UGC) industry. With no prior background in marketing, Kate mastered direct response formulas and content creation strategies, proving that anyone can succeed in this field with determination and passion.
Through her unique approach, Kate has successfully secured deals with major brands like Rimmel London, Biore, and Curology, demonstrating the power and effectiveness of her strategies. The UGC Shortcut program is a step-by-step guide that shares Kate's exact strategies for achieving success as a UGC creator. Through this program, Kate and Rebel Socials aim to inspire others to follow in her footsteps, breaking down barriers and making success accessible to all.
Rebel Socials offers a range of services, including a UGC Starter Kit, comprehensive UGC Course, and personal mentorship, designed to equip aspiring creators with the skills, strategies, and support needed to succeed in the content creation industry. The UGC Shortcut program emphasizes the importance of strategy, best practices, and ongoing learning, helping creators find success without the need for a large following.
As an industry leader, Kate Rebel and Rebel Socials are dedicated to helping others break free from the constraints of traditional employment, offering a pathway to a fulfilling career in content creation. Through Kate's guidance, mentorship, and the supportive community at Rebel Socials, aspiring creators are finding the confidence and skills necessary to turn their passions into profitable careers.
For more information on Rebel Socials and the UGC Shortcut program, visit their website.
About Rebel Socials
Rebel Socials, founded by UGC expert Kate Rebel, is a revolutionary platform that empowers creatives to turn their passions into successful UGC careers. Offering mentorship, resources, and strategies, including the groundbreaking UGC Shortcut program, Rebel Socials helps aspiring creators navigate the ever-evolving digital landscape, achieve financial freedom, and find fulfillment in their work. With a proven track record of securing deals with major brands, Rebel Socials is a trusted resource for content creators looking to thrive in the competitive digital market.
The organization was named among the best workplaces in healthcare.
HOBOKEN, N.J., May 9, 2023 (Newswire.com)
-
Vytalize Health, a leading risk-bearing provider enablement platform, has been selected as one of Inc. magazine's Best Workplaces for 2023. The list, which will be featured in the May/June issue and on Inc.com, is the result of a thorough evaluation of American companies that excel in establishing outstanding workplaces and company culture.
"Being named to Best Workplaces is an honor that only a small fraction of companies have been able to claim," says Inc. editor-in-chief Scott Omelianuk. "Proving to the world that you're a magnet for talent and have a culture that keeps teams engaged, productive, and proud to come to work is a truly remarkable achievement."
"We are honored to receive this recognition by Inc. magazine. At Vytalize Health, we are dedicated to fostering a culture that values inclusivity, empowerment, and a shared commitment to making a difference. We tackle significant challenges in our work to advance value-based care and always encourage collaboration and support among our employees. We believe that our sense of community and teamwork sets us apart as one of the best places to work," said Faris Ghawi, Co-Founder and CEO.
In 2014, Faris Ghawi and Dr. Amer Alnajar co-founded Vytalize Health to improve healthcare quality and reduce the cost of care through a patient-centered, holistic care delivery model. The company's all-in-one solution, including innovative incentives, smart technology, and a virtual and in-home clinic, empowers independent practices to succeed in value-based care arrangements and has transformed healthcare for hundreds of thousands of patients across the country.
With its ambitious vision of being the best facilitator of people's healing through care that's personalized, evidence-based, and kind, Vytalize Health is making strides by fostering a culture built on a foundation of principles that include transparency, reliability, and optimism. The Vytalize Health team is encouraged to 'think big, but start small' and to 'hold itself to the highest standards' to deliver an unparalleled healthcare experience for its patients. Vytalize Health aims to cultivate a space where its team of high performers feels they are doing their best work and making a sustainable impact on healthcare.
Recently, Vytalize Health closed a $100 million funding round to accelerate its mission of responsible value-based care. Additionally, the company acquired the Independent Physicians of Association of New York, one of the largest physician associations in the US.
About Vytalize Health Vytalize Health is a risk-bearing provider enablement platform addressing the healthcare industry's biggest challenges with its cutting-edge value-based care delivery system. Vytalize partners with more than 3,000 leading providers to improve the quality of care through evidence-based medicine and a patient experience rooted in kindness. By delivering the right data at the right time in the workflow to physicians and their staff, Vytalize makes its partners more efficient and effective, allowing them to focus on proactive, personalized medicine to improve the value of care and lower costs. Learn more at www.vytalizehealth.com.
